What's New/
Submissions
Our submissions
Migraine Foundation Aotearoa New Zealand actively engages with organisations to advocate for the advancement of migraine care, treatment and research in Aotearoa.
Letter of support to Pharmac for funding application of fremanezumab (Ajovy)
30 April 2025
Letter of support to the World Health Organization
For the inclusion of new migraine treatments in the WHO’s Essential Medicines List
3 April 2025
Pharmac Consumer Workshop
7 November 2024
Response to Pharmac’s proposed declining of inactive application for zolmitriptan
7 February 2024
Presentation to the Neurological Advisory Committee meeting (Pharmac)
19 September 2023
Feedback to Pharmac on the Pharmacology and Therapeutics Advisory Committee (PTAC) review of erenumab application on 18 August 2022
December 2022
Application to the Ministry of Health to add questions about migraine to the New Zealand Health Survey
June 2022
Feedback to the Pharmacology and Therapeutics Advisory Committee (PTAC) on their decision regarding funding of erenumab
April 2022
